Connect with us


President Trump and Melania test positive for Coronavirus

US President, Donald Trump and his wife have tested positive for Coronavirus.



President Donald Trump has announced that he and first lady Melania Trump have tested positive for Coronavirus.

The announcement came after Hope Hicks, one of the president’s closest senior advisers tested positive for the virus on Thursday October 1. This made her the highest-profile member of the administration who is in frequent contact with Trump and other top officials to contract the virus.

In a tweet shared on Friday morning, Trump wrote;

Tonight, @FLOTUS and I tested positive for COVID-19. We will begin our quarantine and recovery process immediately. We will get through this TOGETHER!

Trump was last seen in public on Thursday afternoon returning to the White House after a fundraising trip to New Jersey. He did not appear ill, though did not speak to reporters as he walked into his residence.

In a memo issued to reporters around 1 a.m. ET, the President’s physician, Navy Commander Dr. Sean Conley, wrote he received confirmation of the positive tests on Thursday evening.

Conley said;

“The president and first lady are both well at this time, and they plan to remain at home within the White House during their convalescence.

“Rest assured I expect the president to continue carrying out his duties without disruption while recovering, and I will keep you updated on any future developments.”

After announcing the President’s diagnosis, the White House issued a new schedule to reflect several canceled events, including a fundraiser in Washington and a campaign rally in Florida.

Mr. Trump has refused for months to wear a mask in public on all but a few occasions and repeatedly questioned their effectiveness while mocking Mr. Biden for wearing one. Trailing in the polls, the president in recent weeks increasingly held crowded campaign events in defiance of public health guidelines and sometimes state and local governments.

As of October 1, more than 7 million cases have been confirmed in the U.S. There have been more than 205,000 deaths.

Click to comment

Leave a Reply


NPHCDA to address infrastructural gaps in COVID-19 vaccine supply

The Minister disclosed that the NPHCDA is currently assessing gaps related to challenges in the distribution of COVID-19 vaccine.



The Federal Government stated that the National Primary Health Care Development Agency (NPHCDA) with its partners, is working to fix healthcare value chain roadblocks that may affect the fair distribution of Covid-19 vaccines.

This was disclosed on Tuesday in Abuja by the Minister of State for Health, Sen. Olorunnimbe Mamora, at the daily Presidential Task Force briefing on Covid-19.

The Minister disclosed that the agency is currently assessing gaps related to distribution challenges. He said,

  • “In terms of vaccines, the lead agency, NPHCDA,  working with partners, is currently assessing the infrastructural gaps in terms of logistics for cold chain maintenance, storage, supply and distribution. We are also working with the Aviation Ministry to ensure strict enforcement of COVID-19 protocols at the local and international wings of airports across the country, taking cognisance of the high transmissibility of the new strain of the virus already confirmed in many countries.
  • “Particular attention in this regard is therefore being focused on passengers arriving from the UK and South Africa. We appeal to all states to increase testing to enable us to know exactly where we are. This will enable us to put in place measures to check transmission and provide treatment for patients.

The Minister added that the FG is also working to ensure the availability of oxygen tanks in hospitals.

  • “The Federal Government has been making spirited efforts at ensuring availability of oxygen on a short term basis through collaboration with CACOVID, while pursuing the process for nationwide equitable and sustainable oxygen availability at federal tertiary hospitals as well as state-owned hospitals.
  • “It is important to state that the ultimate plan in terms of medical oxygen supply is based on systematic oxygen assessment and gaps identification in the country, bordering on severe disequilibrium, uneven storage/demand ratio, distribution logistics challenges and equipment and plant dilapidation.
  • “Our oxygen availability intervention plan is targeted at immediate, medium and long-term plans with special attention to COVID-19 high burden areas such as FCT, Lagos and  Kaduna.” 

What you should know 

  • It was reported last month that the Federal Ministry of Health (FMOH) disclosed that the Health Sector Next Level Agenda will boost primary healthcare in Nigeria and also catch up with healthcare-related gaps by as much as 60% through the implementation of the Sustainable Development Goals (SDGs).
  • The Minister of Health, Dr Osagie Ehanire, also stated that Nigeria is ready for its Covid-19 vaccination strategy, revealing that the FG plans to acquire vaccines valued at N400 billion.
Continue Reading


Second Wave: 1,354 new cases of Coronavirus recorded in Nigeria

Nigeria records 1,354 new cases of covid-19 on Tuesday, 5th January 2021



The Nigeria Centre for Disease Control on Tuesday January 5, announced that 1,354 new cases of Coronavirus were recorded in Nigeria.

The health agency gave a breakdown of the new cases as follows; Lagos-712, FCT-145, Plateau-117, Kwara-81, Kaduna-54, Sokoto-39, Oyo-38, Rivers-37, Gombe-21, Enugu-20, Akwa Ibom-16, Bauchi-14, Delta-14, Ebonyi-13, Anambra-9, Taraba-8, Edo-8, Kano-3, Osun-2, Ekiti-2, Ogun-1.

There are now 92,705 confirmed cases of Coronavirus in the country and 1,319 deaths have been recorded. 76,396 patients who recovered from the disease have also been discharged.


Second wave

Since December 2020, Nigeria has continued to record significant increases in the number of new cases of the pandemic, which has pushed Nigeria into the second wave of the pandemic.

  • So far in January, the average monthly cases jumped by 59% from an average of 645 cases recorded in December 2020 to 1,025 average cases in January.
  • It also represents 553.7% increase compared to the average of 157 cases recorded in November 2020.
  • According to data from the Nigeria Centre for Disease Control, a total of 21,135 tests were carried out on Tuesday, bringing the total tests to-date to 980,046. The number of recorded cases today represents a 6.4% rate of positivity tests.
Continue Reading


UK scientists worry vaccines may not work on South African Covid-19 strain

Scientists in the UK are worried that newly developed Covid-19 vaccines may not be able to protect against new strain of the virus.



UK scientists are worried that the Covid-19 vaccines being rolled out in Britain may not be able to protect against a new strain of the coronavirus that emerged in South Africa and has spread to other parts of the globe, according to Reuters.

The British Health Secretary, Matt Hancock, while citing a conversation he had with his South African counterpart, said he was very worried about the variant discovered in South Africa as he believes that it is more of a problem than the UK variant.

The new strain of the coronavirus in South Africa is driving a surge in Covid-19 cases in the country, and just like the strain in the UK, it appears to be more infectious than the previous mutations.

What the Scientists are saying

Simon Clarke, an associate professor in cellular microbiology at the University of Reading, said that while both variants had some new features in common, the one found in South Africa has a number of additional mutations, which are concerning.

Going further, he said, ‘’These included more extensive alterations to a key part of the virus known as the spike protein – which the virus uses to infect human cells – and may make the virus less susceptible to the immune response triggered by the vaccines.’’

Lawrence Young, a virologist and professor of molecular oncology at Warwick University, also noted that the South African variant has “multiple spike mutations”.

He said, “The accumulation of more spike mutations in the South African variant are more of a concern and could lead to some escape from immune protection.’’

However, the South African Health Minister, Zweli Mkhize, said last month that there is no evidence that the South African variant is more transmissible or causes more severe disease than the U.K. variant. He pointed out that 2 variants developed independently, and there’s evidence that the U.K. strain predates the South African one.

Scientists including BioNTech CEO Ugur Sahin and John Bell, Regius Professor of Medicine at the University of Oxford, said they are testing the vaccines against the new variants and could possibly make any required changes in around six weeks.

Public Health England said there was currently little or no evidence to suggest Covid-19 vaccines would not protect against the mutated virus variants.

The world’s richest countries have started vaccinating their populations to safeguard against a disease that has killed 1.8 million people and crushed the global economy.

What you should know

  • It can be recalled that a new strain of the coronavirus disease which spreads faster was detected in the UK and South Africa, spreading to other countries.
  • The UK government also announced new travel restrictions on passengers coming from South Africa with effect from December 24, to protect public health due to a reported outbreak of Covid-19, with a variant strain spreading in some provinces.
  • The easing of restrictions in South Africa, several months ago, has seen a surge in coronavirus cases in the country, and a second wave is now coinciding with the summer holidays.
  • Scientists say both the South African and UK variants are associated with a higher viral load, meaning a greater concentration of virus particles in patients’ bodies, possibly contributing to increased transmission.
Continue Reading


Follow us on Twitter

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 92 other subscribers